The HIV-1 Env Protein: a Coat of Many Colors

Overview

Journal Curr HIV/AIDS Rep

Publisher Current Science

Specialty Infectious Diseases

Date 2012 Jan 13

PMID 22237899

Citations 48

Authors

Kathryn Twigg Arrildt

Sarah Beth Joseph

Ronald Swanstrom

Affiliations

Soon will be listed here.

Abstract

HIV-1 is completely dependent upon the Env protein to enter cells. The virus typically replicates in activated CD4+ T cells due to viral entry requirements for the CCR5 coreceptor and for high surface levels of the CD4 receptor. This is the case for the transmitted virus and for most of the virus sampled in the blood. Over the course of infection, the env gene can evolve to encode a protein with altered receptor and coreceptor usage allowing the virus to enter alternative host cells. In about 50% of HIV-1 infections, the viral population undergoes coreceptor switching, usually late in disease, allowing the virus to use CXCR4 to enter a different subset of CD4+ T cells. Neurocognitive disorders occur in about 10% of infections, also usually late in disease, but caused (ultimately) by viral replication in the brain either in CD4+ T cells or macrophage and/or microglia. Expanded host range is significantly intertwined with pathogenesis. Identification and characterization of such HIV-1 variants may be useful for early detection which would allow intervention to reduce viral pathogenesis in these alternative cell types.

Citing Articles

The Role of Peptides in Combatting HIV Infection: Applications and Insights.

Helmy N, Parang K Molecules. 2024; 29(20).

PMID: 39459319 PMC: 11510642. DOI: 10.3390/molecules29204951.

Help or Hinder: Protein Host Factors That Impact HIV-1 Replication.

Moezpoor M, Stevenson M Viruses. 2024; 16(8).

PMID: 39205255 PMC: 11360189. DOI: 10.3390/v16081281.

The Question of HIV Vaccine: Why Is a Solution Not Yet Available?.

Libera M, Caputo V, Laterza G, Moudoud L, Soggiu A, Bonizzi L J Immunol Res. 2024; 2024:2147912.

PMID: 38628675 PMC: 11019575. DOI: 10.1155/2024/2147912.

Stoichiometry for entry and binding properties of the Env protein of R5 T cell-tropic HIV-1 and its evolutionary variant of macrophage-tropic HIV-1.

Bonner X, Sondgeroth A, McCue A, Nicely N, Tripathy A, Spielvogel E mBio. 2024; 15(4):e0032124.

PMID: 38426750 PMC: 11210212. DOI: 10.1128/mbio.00321-24.

Impedimetric antimicrobial peptide biosensor for the detection of human immunodeficiency virus envelope protein gp120.

Uygun Z, Tasoglu S iScience. 2024; 27(3):109190.

PMID: 38414859 PMC: 10897921. DOI: 10.1016/j.isci.2024.109190.

References

Crowe S, Zhu T, Muller W . The contribution of monocyte infection and trafficking to viral persistence, and maintenance of the viral reservoir in HIV infection. J Leukoc Biol. 2003; 74(5):635-41. DOI: 10.1189/jlb.0503204. View

Dumonceaux J, Nisole S, Chanel C, Quivet L, Amara A, Baleux F . Spontaneous mutations in the env gene of the human immunodeficiency virus type 1 NDK isolate are associated with a CD4-independent entry phenotype. J Virol. 1998; 72(1):512-9. PMC: 109402. DOI: 10.1128/JVI.72.1.512-519.1998. View

Lee B, Sharron M, Montaner L, Weissman D, Doms R . Quantification of CD4, CCR5, and CXCR4 levels on lymphocyte subsets, dendritic cells, and differentially conditioned monocyte-derived macrophages. Proc Natl Acad Sci U S A. 1999; 96(9):5215-20. PMC: 21844. DOI: 10.1073/pnas.96.9.5215. View

Huang W, Toma J, Fransen S, Stawiski E, Reeves J, Whitcomb J . Coreceptor tropism can be influenced by amino acid substitutions in the gp41 transmembrane subunit of human immunodeficiency virus type 1 envelope protein. J Virol. 2008; 82(11):5584-93. PMC: 2395220. DOI: 10.1128/JVI.02676-07. View

Ritola K, Robertson K, Fiscus S, Hall C, Swanstrom R . Increased human immunodeficiency virus type 1 (HIV-1) env compartmentalization in the presence of HIV-1-associated dementia. J Virol. 2005; 79(16):10830-4. PMC: 1182623. DOI: 10.1128/JVI.79.16.10830-10834.2005. View

Naif H, Li S, Alali M, SLOANE A, Wu L, Kelly M . CCR5 expression correlates with susceptibility of maturing monocytes to human immunodeficiency virus type 1 infection. J Virol. 1998; 72(1):830-6. PMC: 109444. DOI: 10.1128/JVI.72.1.830-836.1998. View

MEURET G, Bammert J, Hoffmann G . Kinetics of human monocytopoiesis. Blood. 1974; 44(6):801-16. View

Peters P, Duenas-Decamp M, Sullivan W, Brown R, Ankghuambom C, Luzuriaga K . Variation in HIV-1 R5 macrophage-tropism correlates with sensitivity to reagents that block envelope: CD4 interactions but not with sensitivity to other entry inhibitors. Retrovirology. 2008; 5:5. PMC: 2268948. DOI: 10.1186/1742-4690-5-5. View

Arfi V, Riviere L, Jarrosson-Wuilleme L, Goujon C, Rigal D, Darlix J . Characterization of the early steps of infection of primary blood monocytes by human immunodeficiency virus type 1. J Virol. 2008; 82(13):6557-65. PMC: 2447095. DOI: 10.1128/JVI.02321-07. View

10.

Taylor B, Foulke J, Flinko R, Heredia A, DeVico A, Reitz M . An alteration of human immunodeficiency virus gp41 leads to reduced CCR5 dependence and CD4 independence. J Virol. 2008; 82(11):5460-71. PMC: 2395218. DOI: 10.1128/JVI.01049-07. View

11.

Tscherning C, Alaeus A, Fredriksson R, Bjorndal A, Deng H, Littman D . Differences in chemokine coreceptor usage between genetic subtypes of HIV-1. Virology. 1998; 241(2):181-8. DOI: 10.1006/viro.1997.8980. View

12.

Marras D, Bruggeman L, Gao F, Tanji N, Mansukhani M, Cara A . Replication and compartmentalization of HIV-1 in kidney epithelium of patients with HIV-associated nephropathy. Nat Med. 2002; 8(5):522-6. DOI: 10.1038/nm0502-522. View

13.

Hwang S, Boyle T, Lyerly H, Cullen B . Identification of the envelope V3 loop as the primary determinant of cell tropism in HIV-1. Science. 1991; 253(5015):71-4. DOI: 10.1126/science.1905842. View

14.

Pillai S, Kosakovsky Pond S, Liu Y, Good B, Strain M, Ellis R . Genetic attributes of cerebrospinal fluid-derived HIV-1 env. Brain. 2006; 129(Pt 7):1872-83. DOI: 10.1093/brain/awl136. View

15.

Ince W, Zhang L, Jiang Q, Arrildt K, Su L, Swanstrom R . Evolution of the HIV-1 env gene in the Rag2-/- gammaC-/- humanized mouse model. J Virol. 2010; 84(6):2740-52. PMC: 2826074. DOI: 10.1128/JVI.02180-09. View

16.

Musich T, Peters P, Duenas-Decamp M, Gonzalez-Perez M, Robinson J, Zolla-Pazner S . A conserved determinant in the V1 loop of HIV-1 modulates the V3 loop to prime low CD4 use and macrophage infection. J Virol. 2010; 85(5):2397-405. PMC: 3067776. DOI: 10.1128/JVI.02187-10. View

17.

Hunt P, Harrigan P, Huang W, Bates M, Williamson D, McCune J . Prevalence of CXCR4 tropism among antiretroviral-treated HIV-1-infected patients with detectable viremia. J Infect Dis. 2006; 194(7):926-30. DOI: 10.1086/507312. View

18.

Chohan B, Lang D, Sagar M, Korber B, Lavreys L, Richardson B . Selection for human immunodeficiency virus type 1 envelope glycosylation variants with shorter V1-V2 loop sequences occurs during transmission of certain genetic subtypes and may impact viral RNA levels. J Virol. 2005; 79(10):6528-31. PMC: 1091724. DOI: 10.1128/JVI.79.10.6528-6531.2005. View

19.

Alexander M, Lynch R, Mulenga J, Allen S, Derdeyn C, Hunter E . Donor and recipient envs from heterosexual human immunodeficiency virus subtype C transmission pairs require high receptor levels for entry. J Virol. 2010; 84(8):4100-4. PMC: 2849512. DOI: 10.1128/JVI.02068-09. View

20.

Richman D, Wrin T, Little S, Petropoulos C . Rapid evolution of the neutralizing antibody response to HIV type 1 infection. Proc Natl Acad Sci U S A. 2003; 100(7):4144-9. PMC: 153062. DOI: 10.1073/pnas.0630530100. View